From SBA-financed first-practice purchases to private equity recaps, learn which deal structure fits your situation — and how to negotiate terms that protect your investment in an eye care practice.
Buying or selling an optometry practice involves more than agreeing on a price. The deal structure — how the purchase price is financed, paid out, and secured — can make or break a transaction. Most optometry practice acquisitions in the lower middle market ($1M–$4M revenue) involve some combination of SBA debt, seller financing, and buyer equity, with the seller often staying on as a transitioning associate for 1–3 years to protect patient retention. For practices being acquired by private equity-backed vision care platforms, equity recapitalizations offer sellers a path to partial liquidity while maintaining upside. This guide breaks down the three most common deal structures used in optometry practice acquisitions, walks through real-world scenarios at typical valuation multiples of 3x–5.5x EBITDA, and provides negotiation guidance specific to the clinical, regulatory, and operational dynamics of independent eye care practices.
Find Optometry Practice Businesses For SaleAsset Purchase with Seller Financing
The buyer acquires the tangible and intangible assets of the practice — including equipment, patient records, lease rights, goodwill, and the practice name — while the seller finances 10–20% of the purchase price through a promissory note. The buyer typically contributes 10–15% equity, and the remainder may come from conventional lending or an SBA loan. A 2–3 year transition employment agreement keeps the selling optometrist in the chair to protect patient relationships and support continuity.
Pros
Cons
Best for: First-time optometry practice buyers purchasing a solo or small-group practice from a retiring OD who wants a clean exit but needs some deferred proceeds to bridge to full retirement income.
SBA 7(a) Loan with Full Financing
The SBA 7(a) program is the most common financing vehicle for independent optometry practice acquisitions under $5M. The buyer injects 10–20% equity, and the SBA-backed lender finances the balance up to $5M at competitive rates and terms of 10 years. Optometry practices qualify as eligible businesses, and lenders familiar with healthcare practice acquisitions will underwrite based on practice EBITDA, patient panel stability, and the buyer's clinical credentials and personal financial profile. The seller may or may not remain involved post-close.
Pros
Cons
Best for: Associate optometrists or early-career ODs buying their first practice who have strong clinical track records, good personal credit, and access to 10–20% equity from personal savings, family, or a 401(k) rollover (ROBS structure).
Equity Recapitalization with PE-Backed Platform
A private equity-backed vision care consolidator acquires a majority stake (typically 60–80%) in the optometry practice, with the selling OD rolling 20–40% of their equity into the acquiring platform. The seller receives immediate liquidity on the majority of their equity value while retaining minority upside tied to the platform's future growth and eventual exit. The selling OD typically continues as a clinical lead for 3–5 years under a long-term employment agreement with defined compensation and performance incentives.
Pros
Cons
Best for: Established optometry practice owners with $2M–$4M in revenue who want partial liquidity now, continued clinical involvement, and exposure to a potential second liquidity event when the PE platform eventually exits or recapitalizes.
First-time buyer acquiring a solo OD retirement practice via SBA financing
$1,050,000
Buyer equity injection: $105,000 (10%) | SBA 7(a) loan: $840,000 (80%) | Seller note: $105,000 (10%)
Practice generating $950,000 in annual revenue with $280,000 EBITDA (29% margin), valued at 3.75x EBITDA. SBA loan at 10-year term, current variable rate. Seller note at 6% interest over 5 years, subordinated to SBA lien. Seller remains as part-time associate OD for 24 months at $85,000 annual compensation to support patient transition. Insurance contracts to be re-credentialed within 60 days of close.
Associate OD buyout of a two-doctor group practice with optical dispensary
$2,400,000
Buyer equity injection: $360,000 (15%) | SBA 7(a) loan: $1,920,000 (80%) | Seller note: $120,000 (5%)
Practice generating $2.1M in annual revenue with $630,000 EBITDA (30% margin), valued at 3.8x EBITDA. Optical dispensary accounts for 35% of total revenue with 55% gross margins. SBA loan structured over 10 years. Seller note at 5.5% over 3 years, subject to SBA standby requirement for first 24 months. Selling OD employed full-time for 36 months at $175,000 per year with non-compete covering a 10-mile radius. Full equipment inventory and condition report completed as part of due diligence; $95,000 capital expenditure reserve negotiated as price concession.
PE-backed vision care platform recapitalization of an established multi-location group
$6,500,000
Cash to seller at close: $4,550,000 (70%) | Rolled equity in platform: $1,950,000 (30%)
Two-location optometry group generating $3.8M in annual revenue with $1.1M EBITDA (29% margin), valued at approximately 5.9x EBITDA reflecting scale and optical retail premium. Seller rolls 30% equity into PE platform at same valuation. Selling OD signs 5-year employment agreement at $220,000 base salary plus performance bonus tied to location EBITDA growth. Management services agreement (MSO) structure implemented to comply with state corporate practice restrictions. Second liquidity event projected in 4–6 years at platform exit.
Find Optometry Practice Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
The most common structure is an SBA 7(a) loan covering 80–90% of the purchase price, with the buyer injecting 10–20% equity and the seller sometimes holding a subordinated note for 5–10% of the price. A transition employment agreement keeping the selling OD in the practice for 1–3 years is nearly universal in independent practice acquisitions because patient relationships in optometry are highly personal and attrition risk is real.
Truly zero-down acquisitions are rare and difficult to finance through traditional channels. SBA lenders require a minimum 10% equity injection. However, buyers can reduce their cash requirement by using a 401(k) ROBS rollover, negotiating seller financing for a portion of the equity injection, or structuring an earnout that defers a portion of the purchase price — effectively reducing the upfront cash needed at close.
Insurance contracts do not automatically transfer to a new owner. The buyer must apply for re-credentialing with each payer under their own NPI and tax identification number. This process can take 60–120 days depending on the payer, and some managed vision plans like VSP have specific requirements around ownership structure. During the credentialing gap, practices may need to bill under the seller's credentials with an assignment arrangement — a process that should be reviewed by a healthcare attorney to ensure compliance.
Optometry practices in the lower middle market typically trade at 3x–5.5x EBITDA. Solo practices with high owner dependence and older equipment tend toward the lower end of that range (3x–4x). Practices with strong optical retail revenue, associate optometrists already in place, and modern diagnostic equipment command premiums toward 4.5x–5.5x. Multi-location groups being acquired by PE-backed consolidators can achieve 5x–7x EBITDA when platform synergies and scale are factored in.
In an asset purchase — the most common structure — staff employment is not automatically assumed by the buyer. Buyers typically offer employment to existing staff as a condition of closing, but should review each employee's compensation, credentialing status, non-compete and non-solicitation agreements, and benefit obligations before doing so. Key staff like opticians and front desk coordinators who know patients by name are critical retention assets, and their continued employment should be a negotiation priority.
Most optometry practice acquisitions are structured as asset sales rather than stock sales. Asset sales allow the buyer to select which assets and liabilities to assume — avoiding unknown historical liabilities — and allow both parties to allocate the purchase price across asset classes for tax purposes. Sellers generally prefer stock sales because gain is taxed at lower long-term capital gains rates, but buyers resist them due to liability exposure. The compromise is often a higher purchase price in exchange for the seller accepting an asset sale structure, with careful attention to personal versus enterprise goodwill allocation to minimize the seller's ordinary income exposure.
More Optometry Practice Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers